M1032 — Adults currently taking pharmacotherapy for oud
M1032 is a HCPCS Level II code for adults currently taking pharmacotherapy for oud. It belongs to the Medical Services section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusM
Measurement code. Used for reporting purposes only; never paid.
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
The CMS record for M1032
- Long descriptor
- Adults currently taking pharmacotherapy for oud
- Short descriptor
- Adt tkng pharmthry for oud
- Added
- January 1, 2019
- BETOS
- Z2
- Pricing indicator
- 00 — Not priced by Part B
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.
Codes adjacent to M1032
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If M1032 is not quite right, the correct code is very often within a few positions of it.
- M1024Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five. either phq-9 or phq-9m score was not assessed or is greater than or equal to fiveterminated
- M1025Patients who were in hospice at any time during the performance periodterminated
- M1026Patients who were in hospice at any time during the performance periodterminated
- M1027Imaging of the head (ct or mri) was obtained
- M1028Documentation of patients with primary headache diagnosis and imaging other than ct or mri obtained
- M1029Imaging of the head (ct or mri) was not obtained, reason not given
- M1030Patients with clinical indications for imaging of the headterminated
- M1031Patients with no clinical indications for imaging of the headterminated
- M1033Pharmacotherapy for oud initiated after june 30th of performance periodterminated
- M1034Adults who have at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days
- M1035Adults who are deliberately phased out of medication assisted treatment (mat) prior to 180 days of continuous treatment
- M1036Adults who have not had at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days
- M1037Patients with a diagnosis of lumbar spine region cancer at the time of the procedure
- M1038Patients with a diagnosis of lumbar spine region fracture at the time of the procedure
- M1039Patients with a diagnosis of lumbar spine region infection at the time of the procedure
- M1040Patients with a diagnosis of lumbar idiopathic or congenital scoliosis
Questions about M1032
What is HCPCS code M1032?
M1032 is a HCPCS Level II code for adults currently taking pharmacotherapy for oud. It sits in the Medical Services section.
Does Medicare cover M1032?
The CMS HCPCS file marks M1032 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
How is M1032 paid under the physician fee schedule?
M1032 carries PFS status code M. Measurement code. Used for reporting purposes only; never paid.